Author
Listed:
- Martin J. Pfeiffer
(Max Planck Institute for Molecular Biomedicine
Chemical Genomics Centre of the Max Planck Society
University Hospital Münster)
- Roberto Quaranta
(Max Planck Institute for Molecular Biomedicine
Chemical Genomics Centre of the Max Planck Society)
- Ilaria Piccini
(Max Planck Institute for Molecular Biomedicine
University of Münster Medical School)
- Jakob Fell
(Max Planck Institute for Molecular Biomedicine
Chemical Genomics Centre of the Max Planck Society)
- Jyoti Rao
(Max Planck Institute for Molecular Biomedicine
Chemical Genomics Centre of the Max Planck Society
Harvard Medical School and Brigham and Women’s Hospital)
- Albrecht Röpke
(University Hospital Münster)
- Guiscard Seebohm
(University of Münster Medical School)
- Boris Greber
(Max Planck Institute for Molecular Biomedicine
Chemical Genomics Centre of the Max Planck Society
RheinCell Therapeutics GmbH)
Abstract
Master cell fate determinants are thought to induce specific cell lineages in gastrulation by orchestrating entire gene programs. The T-box transcription factor EOMES (eomesodermin) is crucially required for the development of the heart—yet it is equally important for endoderm specification suggesting that it may act in a context-dependent manner. Here, we define an unrecognized interplay between EOMES and the WNT signaling pathway in controlling cardiac induction by using loss and gain-of-function approaches in human embryonic stem cells. Dose-dependent EOMES induction alone can fully replace a cocktail of signaling molecules otherwise essential for the specification of cardiogenic mesoderm. Highly efficient cardiomyocyte programming by EOMES mechanistically involves autocrine activation of canonical WNT signaling via the WNT3 ligand, which necessitates a shutdown of this axis at a subsequent stage. Our findings provide insights into human germ layer induction and bear biotechnological potential for the robust production of cardiomyocytes from engineered stem cells.
Suggested Citation
Martin J. Pfeiffer & Roberto Quaranta & Ilaria Piccini & Jakob Fell & Jyoti Rao & Albrecht Röpke & Guiscard Seebohm & Boris Greber, 2018.
"Cardiogenic programming of human pluripotent stem cells by dose-controlled activation of EOMES,"
Nature Communications, Nature, vol. 9(1), pages 1-8, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-017-02812-6
DOI: 10.1038/s41467-017-02812-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-017-02812-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.